Surrey Heartlands

Joint Formulary & PAD

Tofacitinib - Axial spondyloarthritis

You are here : Home > Formulary Search > Tofacitinib - Axial spondyloarthritis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Tablets
  • Tablets (slow release)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
ICB
NICE
Restrictions / Comments :
Important
For use in ankylosing spondylitis only
Documents :
 
Evidence Review
Tofacitinib in Axial Spondyloarthritis NICE TA920 Briefing paper 19Oct23.pdf
Webpage
Tofacitinib for treating active ankylosing spondylitis NICE TA920

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Tofacitinib
Indication :
Axial spondyloarthritis
Group Name :
Keywords :
ankylosing spondylitis, AS
Brand Names Include :
Xeljanz
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Axial spondyloarthritis
Supporting Documents :
2

Other Indications

Below are listed other indications that Tofacitinib is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Axial spondyloarthritis.

Committee Recommendations (2)

05 Feb 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) approves the updated spondyloarthritis treatment pathway.

06 Dec 23 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) approves tofacitinib as a treatment option in line with the recommendations made in NICE TA920, for treating ankylosing spondylitis.

Tofacitinib for this indication will be considered as RED on the traffic light system (treatment should be initiated and continued by specialist clinicians).

Primary care prescribers should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient's medication.

Treatment pathway is available on separate guidelines page.